These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 7509643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR, Gardell SJ.
    Thromb Haemost; 1992 Aug 03; 68(2):165-9. PubMed ID: 1412162
    [Abstract] [Full Text] [Related]

  • 3. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
    van Giezen JJ, Minkema J, Bouma BN, Jansen JW.
    Blood Coagul Fibrinolysis; 1993 Dec 03; 4(6):869-75. PubMed ID: 7511944
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M, Lijnen HR, Keber D, Collen D.
    Thromb Haemost; 1989 Dec 29; 62(4):1083-7. PubMed ID: 2515603
    [Abstract] [Full Text] [Related]

  • 6. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.
    Korninger C, Collen D.
    Thromb Haemost; 1981 Aug 28; 46(2):561-5. PubMed ID: 6795744
    [Abstract] [Full Text] [Related]

  • 7. Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma.
    Declerck PJ, Lijnen HR, Verstreken M, Collen D.
    Thromb Haemost; 1991 Apr 08; 65(4):394-8. PubMed ID: 2057921
    [Abstract] [Full Text] [Related]

  • 8. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV, Barrertt-Bergshoeff M, Hekkenberg RT, Rijken DC.
    Thromb Haemost; 1999 Apr 08; 81(4):605-12. PubMed ID: 10235448
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN, Lee SC, Jackson KW, Tae WC, Schwartzott DG, McKee PA.
    Thromb Haemost; 1998 Oct 08; 80(4):637-44. PubMed ID: 9798984
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D, Van Hoef B, Schlott B, Hartmann M, Gührs KH, Lijnen HR.
    Eur J Biochem; 1993 Aug 15; 216(1):307-14. PubMed ID: 7689966
    [Abstract] [Full Text] [Related]

  • 12. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA, Booth NA, Croll AM, Bennett B.
    Thromb Haemost; 1993 Aug 02; 70(2):301-6. PubMed ID: 8236139
    [Abstract] [Full Text] [Related]

  • 13. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
    Andrew M, Brooker L, Leaker M, Paes B, Weitz J.
    Thromb Haemost; 1992 Sep 07; 68(3):325-30. PubMed ID: 1440499
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasminogen activation and lysis of blood clots induced by cells in vitro.
    Knox P, Crooks S.
    J Cell Physiol; 1988 Jun 07; 135(3):467-73. PubMed ID: 2456288
    [Abstract] [Full Text] [Related]

  • 16. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L, Sandesara J, Yang G, Vagher JP, Caprini JA.
    Thromb Haemost; 1986 Aug 20; 56(1):71-9. PubMed ID: 2946093
    [Abstract] [Full Text] [Related]

  • 17. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species.
    Lijnen HR, De Wreede K, Demarsin E, Collen D.
    Thromb Haemost; 1984 Aug 31; 52(1):31-3. PubMed ID: 6495261
    [Abstract] [Full Text] [Related]

  • 18. Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis.
    Sabovic M, Lijnen HR, Keber D, Collen D.
    Thromb Haemost; 1990 Nov 30; 64(3):450-4. PubMed ID: 2096491
    [Abstract] [Full Text] [Related]

  • 19. Acceleration of plasma clot lysis by an antibody to alpha 2-antiplasmin.
    Reed GL, Matsueda GR, Haber E.
    Trans Assoc Am Physicians; 1988 Nov 30; 101():250-6. PubMed ID: 2480017
    [No Abstract] [Full Text] [Related]

  • 20. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG.
    Blood Coagul Fibrinolysis; 2010 Sep 30; 21(6):584-7. PubMed ID: 20683324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.